Panel Discussion: Closing the Gap Between Innovation and Impact: Patient & Advocacy Perspectives in Modern Dermatology Drug Development
Time: 3:30 pm
day: Day Two PM
Details:
- What makes a trial truly worth participating in from a patient’s and dermatologist’s perspective? What are the key considerations – pros and cons?
- How can developers better reflect patient-perceived benefit, to ensure quality of life and daily function are both addressed as a holistic measure of disease improvement?
- Highlighting the importance of early and meaningful patient involvement in shaping trial goals, eligibility criteria and logistics to ensure trials reflect patient priorities
- Where do patients feel most underserved in dermatology today? What are the advocacy community’s top priorities for addressing gaps in care, support, and treatment innovation for stigmatized or neglected conditions?
- What limits the real-world impact of recent dermatology advances? How can industry meaningfully partner with advocacy groups to improve reach, education, and equitable access to treatment through Early Access Programs (EAPs) & Open Label Extensions (OLEs)?
Speakers:
